With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
We’re talking about the Food and Drug Administration (FDA), which is nothing like the National Institute of Health and Care Excellence (NICE). Here’s an interesting read on how NICE can curb cancer drug prices in a way US regulations definitely do not.